A specialty biopharmaceutical business focused on treatments for rare diseases and specialty conditions, with products spanning immunology, hematology, neuroscience, and genetic disorders. The company built a portfolio of high-margin therapies including treatments for ADHD and hereditary angioedema ...
1 member of Congress has disclosed 1 trade in Shire plc Ordinary Shares (SHPGF), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-07-31 | Greg Gianforte | buy | $50K – $100K |